Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Mater Horiz ; 2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38545861

ABSTRACT

The growing need for high-power and compact-size microelectronic integrated circuits (ICs) in modern microelectronic industries and 5G communication systems demands low dielectric constant (κ) polymer dielectrics with excellent temperature capability, mechanical property and processability. However, conventional molecular design strategies often face difficulties of a trade-off between optimizing the dielectric performance of polymers and maintaining the aforementioned properties. Herein, we present an innovative and facile strategy that utilizes the space charge distribution characteristics of the target co-monomer to solve this trade-off. Based on this design strategy, a novel polyaryl ether ketone (PAEK) with two different charge distribution units (BAF and SBI) was designed and synthesized. Both the experimental results and computational simulations confirm that these two components serve to weaken the polarization of molecular chains in the electric field, induce higher molecular chain packing density and fewer weaknesses, and synchronously regulate the κ, dielectric loss (tan δ), thermal and mechanical properties and processability by generating a strong inter-chain electrostatic interaction. The resultant copolymer, PAEK-4F6S, exhibits exceptional low κ and tan δ values of 1.98 and 0.0024 at 1 MHz, respectively, and these values remain stable over a broad frequency (1-106 Hz, 8.2-12.4 GHz) and temperature range (30-150 °C). Furthermore, the resultant copolymer demonstrates excellent thermal stability and mechanical properties, with a glass transition temperature (Tg) of 195 °C, 5 wt% decomposition temperature (Td5%) of 498 °C under N2, tensile strength of 63.5 MPa and tensile modulus of 1011.2 MPa, respectively. The synthesis procedure of these resultant copolymers is facile, and they are found to have favorable solution and melt processing properties, making them suitable for processing and scalable production. More importantly, this design strategy is beneficial for lowering the κ and tan δ values, and simultaneously enhancing the comprehensive performances of the objective polymers, which provides a completely novel and facile approach for the design and fabrication of high performance low-κ polymers suitable for the needs of microelectronics and communication fields.

2.
BMC Anesthesiol ; 22(1): 391, 2022 12 16.
Article in English | MEDLINE | ID: mdl-36526971

ABSTRACT

BACKGROUND: The Society for Obstetric Anesthesia and Perinatology recommends a multimodal analgesia regimen for cesarean delivery analgesia. This study aimed to compare the analgesic effects of tramadol alone and combined with butorphanol or flurbiprofen axetil after a cesarean section. METHODS: We performed a retrospective analysis based on the electronic medical records of a teaching hospital in China from January 2018 to January 2020. We collected data on demographic characteristics, anesthesia, analgesia strategy, and pain intensity postoperatively during the first 48 hours. Inadequate postoperative analgesia during this period was defined as an NRS score ≥ 4. We also collected data regarding off-bed activity and intestinal function recovery. Participants were classified into three groups according to analgesia regimens. Groups T, TF, and TB received tramadol, a mixture of tramadol and flurbiprofen axetil, and a combination of tramadol and butorphanol, respectively. Analgesic outcomes were compared using propensity score matching analysis. RESULTS: Data from 2323 cases of caesarean section were included in the analysis, and 521 pairs were matched in each group according to their propensity score. Compared with group T, The inadequate analgesia on pain at rest and pain at movement was lower in group TF (RR: 0.42, 95% CI: 0.36-0.49, P = 0.001 and RR: 0.58, 95% CI: 0.48-0.69, P < 0.001, respectively),and the incidence of inadequate control of pain at movement was higher in group TB (RR: 1.38, 95% CI: 1.22-1.55, P < 0.001). Additionally, the percentage of off-bed activity at 2 days postoperatively was higher in group TB than in groups TF and T (78.7% vs. 68.5 and 78.7% vs. 64.9%, respectively, P < 0.001). The incidence of intestinal function recovery 2 days after cesarean delivery in group TB was higher than that in group TF (73.3% vs. 66.2%, P = 0.013). CONCLUSIONS: Combining tramadol and flurbiprofen axetil could enhance the analgesic effect and be safely used for analgesia after a cesarean section. However, combining tramadol and butorphanol may produce an antagonistic effect.


Subject(s)
Flurbiprofen , Tramadol , Humans , Pregnancy , Female , Tramadol/therapeutic use , Butorphanol/therapeutic use , Retrospective Studies , Cesarean Section , Propensity Score , Pain, Postoperative/drug therapy , Pain, Postoperative/epidemiology , Analgesics, Opioid/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Flurbiprofen/therapeutic use , Analgesics/therapeutic use
3.
Comput Intell Neurosci ; 2022: 9637801, 2022.
Article in English | MEDLINE | ID: mdl-36059401

ABSTRACT

The purpose of this study was to investigate the state estimation problem for the multisensor descriptor fractional systems. Firstly, the descriptor fractional order system was transformed into two nondescriptor fractional order subsystem based on the singular value decomposition method; then, the descriptor fractional Kalman filters for the subsystems were proposed based on projection theory, which effectively solved the state estimation problem of the descriptor fractional order system with singular matrix; on this basis, the track fusion fractional Kalman filter of the multisensor descriptor fractional system is proposed by using the track fusion algorithm. The state estimation accuracy of multisensor descriptor fractional order systems is greatly improved. Simulation results show the effectiveness of the proposed algorithm.

4.
Polymers (Basel) ; 13(21)2021 Oct 28.
Article in English | MEDLINE | ID: mdl-34771279

ABSTRACT

Hot melt extrusion offers an efficient way of increasing the solubility of a poorly soluble drug. Shellac has potential as a pharmaceutical matrix polymer that can be used in this extrusion process, with further advantages for use in enteric drug delivery systems. The rheological property of a material affects the extrusion process conditions. However, the literature does not refer to any published work that investigates the processability of various shellac materials. This work explores various types of shellac and explores their physicochemical and thermal properties along with their processability in the hot melt extrusion application. Physicochemical characterization of the materials was achieved using differential scanning calorimetry, Fourier transform infrared spectroscopy, scanning electron microscopy and energy-dispersive X-ray spectroscopy. Additional processability characterization was achieved using melt flow index and rheology analysis. The results indicated that there was no chemical difference between the various shellac types compared in this study. However, the extrudable temperature ranges and rheological properties of different shellac types varied; SSB 55 Pharma FL had the lowest processing temperature and glass transition temperatures. Due to the shear-thinning behaviours, shellac can be extruded at lower temperatures. This study provides necessary data to determine the processing conditions in hot melt extrusion applications for the range of shellac materials.

5.
Front Med (Lausanne) ; 8: 679159, 2021.
Article in English | MEDLINE | ID: mdl-34124111

ABSTRACT

Background: Postpartum depression (PPD) is a severe psychiatric disorder. Its risk is associated with the cesarean section (CS). Currently, there are few early intervention strategies for these women with PPD who underwent CS. Methods: This was a parallel-group randomized controlled trial of singleton pregnant women who underwent elective CS in a tertiary referral hospital in China from October, 2017 to September, 2019. After operation, patients received randomly tramadol patient-controlled intravenous analgesia (PCIA; 4 mg/ml; TRA group), hydromorphone PCIA (0.04 mg/ml; HYD group), or ropivacaine patient-controlled epidural analgesia (PCEA; 1.5 mg/ml; ROP group) for 48 h in a 1:1:1 ratio. Total blinding during hospitalization was not feasible due to differences between the PCEA and PCIA treatments. All investigators who performed the follow-up were blinded to the group assignment. Outcomes: A total of 1,230 patients were enrolled for eligibility. Intention-to-treat analysis showed reduced incidence of PPD in the TRA group (n = 27 [6.6%]) than that in the HYD (10.2%, OR 1.62, 95% CI 0.98~2.68; p = 0.059) and ROP groups (10.5%, OR 1.66, 95% CI 1.01~2.75; p = 0.046) at 4 weeks post-operation, however, the difference was not statistically significant (Bonferroni corrected p = 0.118, p = 0.098, respectively). Subgroup analysis in high-risk women (preoperative Edinburgh Postpartum Depression Scale [EPDS] ≥10) showed a significantly lower incidence of PPD in the TRA group (16.5%) than in the HYD (32.6%) and ROP groups (30.9%) (Bonferroni corrected p = 0.022 and p = 0.038, respectively). The per-protocol analysis yielded similar results. Reported adverse events (AEs) were mostly mild. None of the women or infant discontinued treatment due to AEs. Conclusions: Tramadol PCIA after CS in high-risk women can help to reduce the risk of PPD at 4 weeks after elective CS. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03309163?term=ETPPD&draw=2&rank=1; ClinicalTrials.gov (NCT03309163).

6.
J Pain Res ; 13: 555-563, 2020.
Article in English | MEDLINE | ID: mdl-32256103

ABSTRACT

PURPOSE: This study aimed to compare the analgesic outcomes between primary and repeated cesarean delivery. PATIENTS AND METHODS: We performed a retrospective analysis based on the medical records of a teaching hospital in China from January 2018 to March 2019. We collected data on demographic characteristics, perioperative complications, anesthesia, and surgical factors for cesarean delivery patients. We also recorded the postoperative analgesic strategy, pain intensity (assessed by the number rating scale) during the first 48 hrs after surgery, hospital cost, and hospital stay. Postoperative inadequate analgesia was defined by a score of ≥ 4 in the number rating scale. Analgesic outcomes after cesarean delivery between primiparas and multiparas were compared using propensity score matching analysis. Moreover, subgroup logistic analysis for different age groups (≥ 35 and < 35 years) was performed to investigate the effect of the maternal category on postoperative inadequate analgesia. RESULTS: A total of 1543 patients were included in the analysis and 571 pairs (1142 patients) were matched in the primiparas and multiparaparas group according to their propensity score. In both the non-matched and matched cohort, the incidence of inadequate analgesia in the primiparas group was lower than that in the multiparas group (16.7% vs. 24.0%, P < 0.001 and 16.1% vs. 23.5%, P = 0.002; respectively). The multiparas group was identified as being at risk of inadequate analgesia after cesarean delivery in both age groups (age ≥ 35 years, odds ratio: 2.18, 95% confidence interval: 1.20-3.95; age < 35 years, odds ratio: 1.43, 95% confidence interval 1.08-1.89). CONCLUSION: Multiparas that undergo a repeat cesarean delivery had a significantly higher risk of inadequate postoperative pain treatment than primiparas. The maternal category should be considered when formulating the postoperative analgesia strategy after cesarean delivery.

7.
Nanoscale ; 11(15): 7166-7175, 2019 Apr 11.
Article in English | MEDLINE | ID: mdl-30919871

ABSTRACT

The stability of superhydrophobicity is crucial for the long-term application of an oil/water separation membrane in harsh environments such as high temperatures and various aggressive solvents. However, achieving such a stable superhydrophobic membrane remains a challenge. In this study, high performance fibrous oil/water separation membranes with a highly stable superhydrophobicity were fabricated by designing a functional polymer containing hydroxyl units. The reaction of hydroxy groups in poly(arylene ether sulfone) with octadecyltrichlorosilane (OTS) produces stable covalent interactions, which greatly enhance the stability of OTS on the PAES-OH (polyarylene ether sulfone containing hydroxy units) fibrous membrane fabricated by electrospinning, thus improving the stability of superhydrophobicity of the membrane. The stability of the OTS layer was characterized by FT-IR, SEM and water contact angle measurement. The results suggest that OTS is highly stable on a PAES-OH membrane, while OTS on a polyethersulfone (PES) fibrous membrane is detached from the fiber during ultrasonic cleaning. The obtained membrane is superhydrophobic, with a water contact angle (CA) as high as 159.2° and a threshold sliding angle (TSA) as low as 7.8° even after ultrasonic cleaning for 3 h. In addition, the oil/water separation experiments indicate that this membrane has an excellent performance in the separation of oil from oil/water mixtures, and oil/water emulsions: the gravity driven flux is 7260-8720 L (m2 h)-1 and the water rejection is over 99%. This study provides a new approach for fabricating oil/water separation membranes with highly stable superhydrophobic properties from the perspective of designing new polymers.

8.
BMC Anesthesiol ; 18(1): 192, 2018 12 19.
Article in English | MEDLINE | ID: mdl-30567490

ABSTRACT

OBJECTIVE: To compare the analgesic effects of patient-controlled intravenous analgesia (PCA) with hydromorphone and sufentanil after thoracic surgery on postoperative pulmonary complications (PPCs). METHODS: A total of 142 patients who were scheduled for thoracic surgery were randomly allocated to receive PCA with hydromorphone (group A: experimental group): hydromorphone 0.2 mg/kg + dezocine 0.5 mg/kg + ramosetron 0.6 mg diluted with normal saline to 200 mL; or with sufentanil (group B: control group): sufentanil 3.0µg/kg + dezocine 0.5 mg/kg + ramosetron 0.6 mg diluted with normal saline to 200 mL. The parameters of intravenous analgesia pump were set as background dose 4 ml/h, PCA dose 1 mL, locking time 15 min. Pain NRS (numerical rating scale), Ramsay sedation score, nausea or vomiting score were evaluated at 0 h, 6 h, 12 h, 24 h, 48 h after operation. The cases of PPCs (atelectasis, pulmonary infection, respiratory failure), CRP (C-reaction protein) and inflammatory cells (white cell count and percentage of neutrophils) and blood gas analysis at 12 h after operation, length of ICU and postoperative stay were recorded for each patient. RESULTS: Data of 136 patients were analyzed. Compared with group B (4[IQR:2,2]), the pain NRS in group A (2[IQR:4,4]) was significantly lower at 6 h after operation (P = 0.000). The CRP in group A (69.79 ± 32.13 mg/L) were lower than group B (76.76 ± 43.42 mg/L) after operation, but the difference was not significant (P = 0.427). No difference of nausea or vomiting was found between group A (7.3%) and group B (5.8%) postoperatively (P = 0.999). The PPCs were happened in 11 patients in group A (16.2%) and 22 patients in group B (32.4%) and the difference between two groups was significant (P = 0.027). Seven patients in group A (10.3%) and eighteen patients in group B (26.5%) had clinical evidence of pneumonia and the difference between two groups was significant (P = 0.014). The length of ICU and postoperative stay in group A were 2.73 h and 1.82 days less than group B respectively but the differences were not significant (P = 0.234, P = 0.186 respectively). CONCLUSION: Compared with sufentanil, hydromorphone may provide better postoperative analgesic effect with less pulmonary complications for patients undergoing thoracic surgery, and it may accelerate patients' rehabilitation. TRIAL REGISTRATION: Randomized Controlled Trials ChiCTR1800014282c . Registered 3 January 2018.


Subject(s)
Hydromorphone/administration & dosage , Postoperative Complications/epidemiology , Sufentanil/administration & dosage , Thoracic Surgical Procedures/methods , Adult , Analgesia, Patient-Controlled/methods , Benzimidazoles/administration & dosage , Blood Gas Analysis , Bridged Bicyclo Compounds, Heterocyclic/administration & dosage , Double-Blind Method , Female , Humans , Intensive Care Units/statistics & numerical data , Length of Stay , Lung Diseases/epidemiology , Lung Diseases/etiology , Lung Diseases/physiopathology , Male , Middle Aged , Pain, Postoperative/drug therapy , Tetrahydronaphthalenes/administration & dosage
9.
Toxicol Appl Pharmacol ; 327: 1-12, 2017 07 15.
Article in English | MEDLINE | ID: mdl-28438631

ABSTRACT

It is well known that liver cancer is a highly aggressive malignancy with poor prognosis. Andrographolide (AD), a major bioactive component of Andrographis paniculata (Burm. F.), is a potential anti-cancer pharmacophore and the synthesis of AD derivatives with better cytotoxicity to cancer cells has attracted considerable attentions. In the present study, we evaluated the in vivo inhibitory effects of ADN-9, a 15-benzylidene substituted derivative of AD, on the growth and metastasis of murine hepatoma H22 using an orthotopic xenograft model and a subcutaneous xenograft model, and we further studied the anti-angiogenic action and the related mechanisms of ADN-9 in vivo and in vitro. Importantly, ADN-9 remarkably suppressed the growth and metastasis of both orthotopic and subcutaneous xenograft tumors, and the serum AFP level in orthotopic hepatoma-bearing mice treated with 100mg/kg ADN-9 (ig.) was decreased to the normal level. We also found that ADN-9 showed stronger abilities than AD in shrinking tumors, suppressing the invasion and metastasis of H22 cells, decreasing the MVD and promoting tumor cell apoptosis in subcutaneous xenograft of mice. Additionally, ADN-9 exhibited stronger inhibitory activity than AD against the migration and VEGF-induced capillary-like tube formation in HUVECs, which was further proved to be associated with attenuating VEGF/VEGFR2/AKT signaling pathway. The present research provides the first evidence that a 15-substituted AD derivative is more promising than the parent compound in therapeutic treatment of liver cancer.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Diterpenes/pharmacology , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms/drug therapy , Neovascularization, Pathologic/prevention & control , Andrographis/chemistry , Animals , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Liver Circulation/drug effects , Liver Neoplasms/blood supply , Liver Neoplasms, Experimental/blood supply , Mice , Mice, Inbred BALB C , Neoplasm Invasiveness/pathology , Neoplasm Metastasis , Neovascularization, Pathologic/pathology , Signal Transduction/drug effects , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Wound Healing/drug effects , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...